← Open Payments lookup

DAWN CALABRESE: Open Payments

NPI 1720587017 · MANAHAWKIN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$306 in 16 payments from 9 companies in 2025. Trend: 2023 $261 · 2024 $568 · 2025 $306

Food & beverage: $306
CompanyPaymentsAmount
ABBVIE INC.4$69
Madrigal Pharmaceuticals2$52
Janssen Biotech, Inc.2$40
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$36
QOL Medical, LLC2$36
Takeda Pharmaceuticals U.S.A., Inc.1$21
GENZYME CORPORATION1$18
GlaxoSmithKline, LLC.1$17
Phathom Pharmaceuticals, Inc.1$16

Products named: REZDIFFRA, CREON, TREMFYA, XIFAXAN, Sucraid, ENTYVIO, LINZESS, DUPIXENT.

Industry payments across NJ — which companies pay providers there.